TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 OVERVIEW OF GERMANY AT-HOME TESTING KITS MARKET 15
1.4 LIMITATIONS 17
1.5 MARKETS COVERED 17
2 MARKET SEGMENTATION 22
2.1 MARKETS COVERED 22
2.2 GEOGRAPHICAL SCOPE 23
2.3 YEARS CONSIDERED FOR THE STUDY 23
2.4 CURRENCY AND PRICING 23
2.5 DBMR TRIPOD DATA VALIDATION MODEL 24
2.6 MULTIVARIATE MODELLING 27
2.7 GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE 27
2.8 MARKET POSITION COVERAGE GRID 28
2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 29
2.10 DBMR MARKET POSITION GRID 30
2.11 SECONDARY SOURCES 32
2.12 ASSUMPTIONS 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 36
4.1 PESTEL ANALYSIS 37
4.2 PORTER'S FIVE FORCES 38
4.3 STRATEGIC INITIATIVES 39
4.4 BRAND ANALYSIS 40
4.5 PRICING ANALYSIS 41
5 GERMANY AT-HOME TESTING KITS MARKET: REGULATIONS 42
5.1 REGULATION IN EUROPE 42
5.2 GUIDELINES FOR TESTING KITS 43
6 GERMANY AT-HOME TESTING KITS MARKET, MARKET OVERVIEW 44
6.1 DRIVERS 46
6.1.1 RISE IN THE ADOPTION OF AT-HOME TESTING KITS DUE TO THE INCREASE IN THE PREVALENCE OF HEALTH DISORDERS 46
6.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES AND ONLINE STORES 46
6.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF STD DIAGNOSIS 47
6.1.4 LOW COST AND EASE TO USE AT-HOME TEST KITS 47
6.2 RESTRAINTS 48
6.2.1 PRODUCT RECALL OF AT-HOME TESTING KITS 48
6.2.2 INACCURACY OF RESULTS BY SELF-TESTING KITS 48
6.2.3 STRINGENT GOVERNMENT REGULATIONS FOR THE MANUFACTURING AND DISTRIBUTION OF TESTING KITS 49
6.3 OPPORTUNITIES 50
6.3.1 EXPANDING BUSINESS THROUGH SUBSIDIARIES 50
6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 50
6.4 CHALLENGES 51
6.4.1 LOW AWARENESS IN SOCIETY 51
6.4.2 REDUCTION IN THE R&D BUDGET 51
7 GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE 52
7.1 OVERVIEW 53
7.2 HEALTH 56
7.2.1 DIABETES KITS 57
7.2.2 KIDNEY FUNCTION TEST KITS 57
7.2.3 LIVER FUNCTION TEST KITS 58
7.2.4 PROTEIN KITS 58
7.2.5 IRON STATUS KITS 58
7.2.6 HEART DISEASE RISK TEST KITS 58
7.2.7 THYROID FUNCTION 58
7.2.8 RED BLOOD CELLS 58
7.2.9 WHITE BLOOD CELLS 58
7.2.10 CLOTTING STATUS 58
7.2.11 HORMONE 58
7.2.12 PSA 58
7.2.13 MENOPAUSE TEST 58
7.2.14 ANXIETY 59
7.2.15 ASTHMA 59
7.2.16 ATRIAL FIBRILLATION 59
7.2.17 GOUT 59
7.2.18 HDL AND LDL CHOLESTROL TEST KITS 59
7.2.19 HIGH BLOOD PRESSURE 59
7.2.20 OTHERS 59
7.3 BEAUTY AND WELLNESS 59
7.3.1 SKIN MICROBIME TEST 60
7.3.2 GENETIC BASED TEST KITS 60
7.3.3 FOOD SENSITIVITY TEST KITS 61
7.3.4 SEX HORMONE 61
7.3.4.1 FEMALE HORMONE TEST 61
7.3.4.2 MALE HORMONE TEST 61
7.3.5 HAIR, NAILS AND SKIN TEST KITS 61
7.3.6 STRESS TEST KITS 61
7.3.7 ALCOHOL FLUSH REACTION 61
7.3.8 CAFFEINE CONSUMPTION 61
7.3.9 DEEP SLEEP 62
7.3.10 MUSCLE COMPOSITION 62
7.3.11 SATURATED FAT 62
7.3.12 SLEEP MOVEMENT 62
7.3.13 ALLERGY TESTING 62
7.3.14 INTOLERANCE TESTING 62
7.3.14.1 LACTOSE INTOLERANCE 62
7.3.14.2 VEGAN INTOLERANCE TESTING 62
7.3.14.3 OTHER TEST 63
7.3.15 GUT MICROBIOME TEST 63
7.3.16 SKIN DNA TEST 63
7.4 STD TEST 63
7.4.1 HIV TEST 64
7.4.2 GONORRHEA TEST 64
7.4.3 SYPHILIS TEST 64
7.4.4 HERPES TEST 64
7.4.5 TRICHOMONIASIS 64
7.4.6 HEPATITIS B 64
7.4.7 HEPATITIS C 65
7.4.8 MEASLES 65
7.4.9 RUBELLA 65
7.4.10 VARICELLA 65
7.4.11 CHLAMYDIA TEST 65
7.4.12 OTHERS 65
7.5 NUTRITION 65
7.5.1 VITAMINS 66
7.5.1.1 D3 66
7.5.1.2 B12 66
7.5.1.3 ACTIVE B12 67
7.5.2 VITALITY 67
7.5.2.1 HEALTH MARKERS 67
7.5.2.2 IRON STATUS 67
7.5.2.3 MINERALS 67
7.5.3 OMEGA 3 TEST 67
7.5.4 IODINE DEFICIENCY TEST 67
7.5.5 ZINC TEST 67
7.5.6 SELENIUM TEST 68
7.5.7 MAGNESIUM BLOOD TEST 68
7.5.8 FERRITIN TEST 68
7.5.9 AMINO ACID TEST 68
7.6 PREGNANCY TEST 68
7.6.1 STRIP TESTS 69
7.6.2 MIDSTREAM TEST 69
7.6.3 CASSETTE TEST 69
7.6.4 DIGITAL TEST 69
7.6.5 HCG URINE TEST 70
7.6.6 HCG BLOOD TEST 70
7.6.7 LH URINE TEST 70
7.6.8 FSH URINE TEST 70
7.7 DRUG ABUSE TEST KITS 70
7.7.1 MARUUANA KITS 71
7.7.2 OPIATES KITS 71
7.7.3 ALCOHOL KITS 71
7.7.4 OTHERS 71
7.8 OVULATION PREDICTOR TEST KIT 71
7.9 OTHERS TEST TYPES 71
7.9.1 MALE INFERTILITY TEST TYPE 72
7.9.2 URINARY TRACT INFECTIONS TEST 72
7.9.3 MENOPAUSE TEST KITS 72
7.9.4 FECAL OCCULT BLOOD TEST 72
7.9.5 OTHERS 72
8 GERMANY AT-HOME TESTING KITS MARKET, BY TYPE 73
8.1 OVERVIEW 74
8.2 STRIP 77
8.2.1 RETAIL PHARMACIES 77
8.2.2 ONLINE PHARMACIES 77
8.2.3 DRUG STORE 77
8.2.4 SUPERMARKET/HYPERMARKET 77
8.2.5 CASSETTES 78
8.2.6 RETAIL PHARMACIES 78
8.2.7 ONLINE PHARMACIES 78
8.2.8 DRUG STORE 78
8.2.9 SUPERMARKET/HYPERMARKET 78
8.2.10 MIDSTREAM 79
8.2.11 RETAIL PHARMACIES 79
8.2.12 ONLINE PHARMACIES 79
8.2.13 DRUG STORE 79
8.2.14 SUPERMARKET/HYPERMARKET 79
8.2.15 DIP CARD 80
8.2.16 RETAIL PHARMACIES 80
8.2.17 ONLINE PHARMACIES 80
8.2.18 DRUG STORE 80
8.2.19 SUPERMARKET/HYPERMARKET 80
8.2.20 TEST PANEL 81
8.2.21 RETAIL PHARMACIES 81
8.2.22 ONLINE PHARMACIES 81
8.2.23 DRUG STORE 81
8.2.24 SUPERMARKET/HYPERMARKET 81
8.3 OTHERS 82
9 GERMANY AT-HOME TESTING KITS MARKET, BY AGE 83
9.1 OVERVIEW 84
9.2 ADULT 86
9.3 GERIATRIC 87
9.4 PEDIATRIC 87
10 GERMANY AT-HOME TESTING KITS MARKET, BY USAGE 88
10.1 OVERVIEW 89
10.2 DISPOSABLE 91
10.3 REUSABLE 92
11 GERMANY AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE 93
11.1 OVERVIEW 94
11.2 BLOOD 96
11.3 SALIVA 97
11.4 URINE 97
11.5 OTHER SAMPLE TYPES 97
12 GERMANY AT-HOME TESTING KITS MARKET, BY INCOME 98
12.1 OVERVIEW 99
12.2 MIDDLE INCOME 101
12.3 LOW INCOME 102
12.4 HIGH INCOME 102
13 GERMANY AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL 103
13.1 OVERVIEW 104
13.2 RETAIL PHARMACIES 106
13.3 ONLINE PHARMACIES 107
13.4 DRUG STORE 107
13.5 SUPERMARKET/HYPERMARKET 107
14 GERMANY AT-HOME TESTING KITS MARKET, COMPANY LANDSCAPE 108
14.1 COMPANY SHARE ANALYSIS: EUROPE 108
15 SWOT ANALYSIS 109
16 COMPANY PROFILE 110
16.1 ABBOTT 110
16.1.1 COMPANY SNAPSHOT 110
16.1.2 REVENUS ANALYSIS 110
16.1.3 PRODUCT PORTFOLIO 111
16.1.4 RECENT DEVELOPMENTS 111
16.2 F. HOFFMANN- LA ROCHE LTD 112
16.2.1 COMPANY SNAPSHOT 112
16.2.2 REVENUE ANALYSIS 112
16.2.3 PRODUCT PORTFOLIO 113
16.2.4 RECENT DEVELOPMENT 113
16.3 SIEMENS HEALTHCARE GMBH 114
16.3.1 COMPANY SNAPSHOT 114
16.3.2 REVENUE ANALYSIS 114
16.3.3 PRODUCT PORTFOLIO 115
16.3.4 RECENT DEVELOPMENTS 115
16.4 QUIDEL CORPORATION. 116
16.4.1 COMPANY SNAPSHOT 116
16.4.2 REVENUE ANALYSIS 116
16.4.3 PRODUCT PORTFOLIO 117
16.4.4 RECENT DEVELOPMENT 117
16.5 CARDINAL HEALTH. 118
16.5.1 COMPANY SNAPSHOT 118
16.5.2 REVENUE ANALYSIS 118
16.5.3 PRODUCT PORTFOLIO 119
16.5.4 RECENT DEVELOPMENTS 119
16.6 ASCENSIA DIABETES CARE HOLDINGS AG. 120
16.6.1 COMPANY SNAPSHOT 120
16.6.2 PRODUCT PORTFOLIO 120
16.6.3 RECENT DEVELOPMENT 120
16.7 B. BRAUN SE MELSUNGEN AG 121
16.7.1 COMPANY SNAPSHOT 121
16.7.2 REVENUE ANALYSIS 121
16.7.3 PRODUCT PORTFOLIO 122
16.7.4 RECENT DEVELOPMENTS 122
16.8 BIOLYTICAL LABORATORIES INC. 123
16.8.1 COMPANY SNAPSHOT 123
16.8.2 PRODUCT PORTFOLIO 123
16.8.3 RECENT DEVELOPMENT 123
16.9 BTNX INC. 124
16.9.1 COMPANY SNAPSHOT 124
16.9.2 PRODUCT PORTFOLIO 124
16.9.3 RECENT DEVELOPMENTS 124
16.10 CARE DIAGNOSTICA 125
16.10.1 COMPANY SNAPSHOT 125
16.10.2 PRODUCT PORTFOLIO 125
16.10.3 RECENT DEVELOPMENTS 125
16.11 DEXCOM, INC. 126
16.11.1 COMPANY SNAPSHOT 126
16.11.2 REVENUE ANALYSIS 126
16.11.3 PRODUCT PORTFOLIO 127
16.11.4 RECENT DEVELOPMENTS 127

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.